The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Organ Preservation Solutions Market Research Report 2025

Global Organ Preservation Solutions Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1901055

No of Pages : 82

Synopsis

The global Organ Preservation Solutions market was valued at US$ 125.2 million in 2023 and is anticipated to reach US$ 246.5 million by 2030, witnessing a CAGR of 9.7% during the forecast period 2024-2030.

North American market for Organ Preservation Solutions is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Organ Preservation Solutions is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Organ Preservation Solutions in Hypothermic Perfusion Preservation (HPP) is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Organ Preservation Solutions include Dr. Franz Köhler Chemie, Teva Pharmaceutical Industries Ltd., Lifeline Scientific, Bristol-Myers Squibb, BioLife Solutions, Inc., XVIVO Perfusion AB, ToleroTech, Inc, CryoLife, Inc. and Claris Lifesciences Limited, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Organ Preservation Solutions, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Organ Preservation Solutions.

Report Scope

The Organ Preservation Solutions market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Organ Preservation Solutions market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Organ Preservation Solutions companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company (Partial List):

  • Dr. Franz Köhler Chemie
  • Teva Pharmaceutical Industries Ltd.
  • Lifeline Scientific
  • Bristol-Myers Squibb
  • BioLife Solutions, Inc.
  • XVIVO Perfusion AB
  • ToleroTech, Inc
  • CryoLife, Inc.
  • Claris Lifesciences Limited
  • BioTime, Inc.
  • 21st Century Medicine

Segment by Type

  • Viaspan
  • Custodial
  • siRNA Transplant Solutions
  • Others

Segment by Application

  • Hypothermic Perfusion Preservation (HPP)
  • Static Cold Storage (SCS)
  • Others

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Organ Preservation Solutions companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Organ Preservation Solutions Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Viaspan
1.2.3 Custodial
1.2.4 siRNA Transplant Solutions
1.2.5 Others
1.3 Market by Application
1.3.1 Global Organ Preservation Solutions Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hypothermic Perfusion Preservation (HPP)
1.3.3 Static Cold Storage (SCS)
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Organ Preservation Solutions Market Perspective (2019-2030)
2.2 Organ Preservation Solutions Growth Trends by Region
2.2.1 Global Organ Preservation Solutions Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Organ Preservation Solutions Historic Market Size by Region (2019-2024)
2.2.3 Organ Preservation Solutions Forecasted Market Size by Region (2025-2030)
2.3 Organ Preservation Solutions Market Dynamics
2.3.1 Organ Preservation Solutions Industry Trends
2.3.2 Organ Preservation Solutions Market Drivers
2.3.3 Organ Preservation Solutions Market Challenges
2.3.4 Organ Preservation Solutions Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Organ Preservation Solutions Players by Revenue
3.1.1 Global Top Organ Preservation Solutions Players by Revenue (2019-2024)
3.1.2 Global Organ Preservation Solutions Revenue Market Share by Players (2019-2024)
3.2 Global Organ Preservation Solutions Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Organ Preservation Solutions Revenue
3.4 Global Organ Preservation Solutions Market Concentration Ratio
3.4.1 Global Organ Preservation Solutions Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Organ Preservation Solutions Revenue in 2023
3.5 Organ Preservation Solutions Key Players Head office and Area Served
3.6 Key Players Organ Preservation Solutions Product Solution and Service
3.7 Date of Enter into Organ Preservation Solutions Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Organ Preservation Solutions Breakdown Data by Type
4.1 Global Organ Preservation Solutions Historic Market Size by Type (2019-2024)
4.2 Global Organ Preservation Solutions Forecasted Market Size by Type (2025-2030)
5 Organ Preservation Solutions Breakdown Data by Application
5.1 Global Organ Preservation Solutions Historic Market Size by Application (2019-2024)
5.2 Global Organ Preservation Solutions Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Organ Preservation Solutions Market Size (2019-2030)
6.2 North America Organ Preservation Solutions Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Organ Preservation Solutions Market Size by Country (2019-2024)
6.4 North America Organ Preservation Solutions Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Organ Preservation Solutions Market Size (2019-2030)
7.2 Europe Organ Preservation Solutions Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Organ Preservation Solutions Market Size by Country (2019-2024)
7.4 Europe Organ Preservation Solutions Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Organ Preservation Solutions Market Size (2019-2030)
8.2 Asia-Pacific Organ Preservation Solutions Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Organ Preservation Solutions Market Size by Region (2019-2024)
8.4 Asia-Pacific Organ Preservation Solutions Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Organ Preservation Solutions Market Size (2019-2030)
9.2 Latin America Organ Preservation Solutions Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Organ Preservation Solutions Market Size by Country (2019-2024)
9.4 Latin America Organ Preservation Solutions Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Organ Preservation Solutions Market Size (2019-2030)
10.2 Middle East & Africa Organ Preservation Solutions Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Organ Preservation Solutions Market Size by Country (2019-2024)
10.4 Middle East & Africa Organ Preservation Solutions Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Dr. Franz Köhler Chemie
11.1.1 Dr. Franz Köhler Chemie Company Detail
11.1.2 Dr. Franz Köhler Chemie Business Overview
11.1.3 Dr. Franz Köhler Chemie Organ Preservation Solutions Introduction
11.1.4 Dr. Franz Köhler Chemie Revenue in Organ Preservation Solutions Business (2019-2024)
11.1.5 Dr. Franz Köhler Chemie Recent Development
11.2 Teva Pharmaceutical Industries Ltd.
11.2.1 Teva Pharmaceutical Industries Ltd. Company Detail
11.2.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.2.3 Teva Pharmaceutical Industries Ltd. Organ Preservation Solutions Introduction
11.2.4 Teva Pharmaceutical Industries Ltd. Revenue in Organ Preservation Solutions Business (2019-2024)
11.2.5 Teva Pharmaceutical Industries Ltd. Recent Development
11.3 Lifeline Scientific
11.3.1 Lifeline Scientific Company Detail
11.3.2 Lifeline Scientific Business Overview
11.3.3 Lifeline Scientific Organ Preservation Solutions Introduction
11.3.4 Lifeline Scientific Revenue in Organ Preservation Solutions Business (2019-2024)
11.3.5 Lifeline Scientific Recent Development
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Detail
11.4.2 Bristol-Myers Squibb Business Overview
11.4.3 Bristol-Myers Squibb Organ Preservation Solutions Introduction
11.4.4 Bristol-Myers Squibb Revenue in Organ Preservation Solutions Business (2019-2024)
11.4.5 Bristol-Myers Squibb Recent Development
11.5 BioLife Solutions, Inc.
11.5.1 BioLife Solutions, Inc. Company Detail
11.5.2 BioLife Solutions, Inc. Business Overview
11.5.3 BioLife Solutions, Inc. Organ Preservation Solutions Introduction
11.5.4 BioLife Solutions, Inc. Revenue in Organ Preservation Solutions Business (2019-2024)
11.5.5 BioLife Solutions, Inc. Recent Development
11.6 XVIVO Perfusion AB
11.6.1 XVIVO Perfusion AB Company Detail
11.6.2 XVIVO Perfusion AB Business Overview
11.6.3 XVIVO Perfusion AB Organ Preservation Solutions Introduction
11.6.4 XVIVO Perfusion AB Revenue in Organ Preservation Solutions Business (2019-2024)
11.6.5 XVIVO Perfusion AB Recent Development
11.7 ToleroTech, Inc
11.7.1 ToleroTech, Inc Company Detail
11.7.2 ToleroTech, Inc Business Overview
11.7.3 ToleroTech, Inc Organ Preservation Solutions Introduction
11.7.4 ToleroTech, Inc Revenue in Organ Preservation Solutions Business (2019-2024)
11.7.5 ToleroTech, Inc Recent Development
11.8 CryoLife, Inc.
11.8.1 CryoLife, Inc. Company Detail
11.8.2 CryoLife, Inc. Business Overview
11.8.3 CryoLife, Inc. Organ Preservation Solutions Introduction
11.8.4 CryoLife, Inc. Revenue in Organ Preservation Solutions Business (2019-2024)
11.8.5 CryoLife, Inc. Recent Development
11.9 Claris Lifesciences Limited
11.9.1 Claris Lifesciences Limited Company Detail
11.9.2 Claris Lifesciences Limited Business Overview
11.9.3 Claris Lifesciences Limited Organ Preservation Solutions Introduction
11.9.4 Claris Lifesciences Limited Revenue in Organ Preservation Solutions Business (2019-2024)
11.9.5 Claris Lifesciences Limited Recent Development
11.10 BioTime, Inc.
11.10.1 BioTime, Inc. Company Detail
11.10.2 BioTime, Inc. Business Overview
11.10.3 BioTime, Inc. Organ Preservation Solutions Introduction
11.10.4 BioTime, Inc. Revenue in Organ Preservation Solutions Business (2019-2024)
11.10.5 BioTime, Inc. Recent Development
11.11 21st Century Medicine
11.11.1 21st Century Medicine Company Detail
11.11.2 21st Century Medicine Business Overview
11.11.3 21st Century Medicine Organ Preservation Solutions Introduction
11.11.4 21st Century Medicine Revenue in Organ Preservation Solutions Business (2019-2024)
11.11.5 21st Century Medicine Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’